Hogan Lovells International LLP remains at the technological forefront of the life sciences sector, integrating advice on data protection, cybersecurity and AI regulations into a comprehensive digital health advisory practice for pharmaceutical and medical technology manufacturers and investors. The practice is also strong in traditional areas of healthcare law, including compliance and competition law advice, financing rounds and sales, market entries and expansions of global health companies into Europe, and representation in and out of court in medical law cases. Jörg Schickert leads on complex internal regulatory matters and contract negotiations, Arne Thiermann is experienced in transactions and has an emergent AI practice, Matthias Schweiger leads on product liability proceedings for pharmaceutical companies, and Tanja Eisenblätter is an experienced litigator in the medical field.
Legal 500 Editorial commentary
Accolades
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
- ‘The merits of the Hogan Lovells team are numerous, including in-depth knowledge of the pharmaceutical and medical device sector, high-profile and always timely legal assistance and full availability to the client. The client's request is handled by the appropriate lawyer with the appropriate level of experience and seniority in relation to the complexity of the work to be performed.’
- 'Very client oriented. Providing high-quality legal advice, combined with a very personable team. Matthias Schweiger is outstanding as a litigator in the healthcare sector.'
- ‘Jörg Schickert has outstanding market and sector experience.’
- ‘The team acts very professionally.’
- ‘We sought a law firm with strong expertise in contract manufacturing, and are highly impressed by the depth of knowledge Hogan Lovells brings to our team in this area. They support us on contractual matters and advise us on specific legal risks. The team we are working with, demonstrates deep legal expertise in life sciences and a proactive approach that has been instrumental in supporting our objectives. Their clarity and precision have added significant value to our evaluation of business models and decision-making process.’
- ‘Jörg Schickert provided valuable support on a complex legal matter, offering clear and well-reasoned advice that proved indispensable to us. He is a pleasure to work with, collaborative, pragmatic and solution-driven.’
Key clients
- Abbvie
- BMS
- CeramTec
- Chimerix/INC
- Cochlear
- Daiichi Sankyo
- Eli Lilly and Company
- Fresenius Kabi
- Incyte
- Novartis
- MorphoSys
- Roche Diagnostics International Ltd
Work highlights
Advised several clients, including Incyte, on various questions around reimbursement issues and AMNOG-specific questions.
Advised several clients, including Roche, Daiichi Sankyo and Novartis on questions concerning the EU AI Act.
Advised clients on matters concerning regulatory aspects of their products, as well as on contracts for supply chains and partnership agreements.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Tanja Eisenblätter
Jörg Schickert
Arne Thiermann
Practice head
Tanja Eisenblätter; Jörg Schickert; Matthias Schweiger; Arne Thiermann